Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall

Circulation

Volumn 100, Issue 14, 1999, Pages 1569-1575

  Zhou, Yi Fu ^a   Shou, Matie ^b   Guetta, Esther ^b   Guzman, Raul ^b   Unger, Ellis F ^b   Yu, Zu Xi ^b   Zhang, Jun ^b   Finkel, Toren ^b   Epstein, Stephen E ^b  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b NONE

Author keywords

Atherosclerosis; Balloon; Cytokines; Restenosis; Viruses

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CAROTID ARTERY; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; NONHUMAN; PRIORITY JOURNAL; RAT; RESTENOSIS;

EID: 0345109241     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.14.1569     Document Type: Article

References (39)

1. Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science. 1994;265:391-394.
2. Zhou YF, Leon MB, Waclawiw MA, Popma JJ, Yu ZX, Finkel T, Epstein SE. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med. 1996;335:624-630.
3. Blum A, Giladi M, Weinberg M, Kaplan G, Pastemack H, Laniado S, Miller H. High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. Am J Cardiol. 1998;81:866-868.
4. 1 in rat aortic allografts: possible mechanism for cytomegalovirus-enhanced graft arteriosclerosis. Arterioscler Thromb. 1994;14:2043-2052.
5. Pasceri V, Cammarota G, Patti G, Cuoco L, Gasbarrini A, Grillo RL, Fedeli G, Gasbarrini G, Maseri A. Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation. 1998;97: 1675-1679.
6. Maass M, Gieffers J. Prominent serological response to Chlamydia pneumoniae in cardiovascular disease. Immunol Infect Dis. 1996;6:65-70.
7. Melnick JL, Hu C, Bursk J, Adam E, DeBakey ME. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J Med Virol. 1994;42:170-174.
8. Adam E, Melnick JL, Probtsfield JL, Petrie BL, Burek J, Bailey KR, McCollum CH, DeBakey ME. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet. 1987; 2:291-293.
9. Zhu J, Quyyumi AA, Norman JE, Csako G, Waclawiw MA, Shearer GM, Grayston JT, Epstein SE. Total pathogen burden contributes incrementally to coronary artery disease risk and to C-reactive protein levels. Circulation. 1998;98(suppl 1):I-42. Abstract.
10. Zhou YF, Guetta E, Yu ZX, Finkel T, Epstein SE. Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells. J Clin Invest. 1996;98:2129-2138.
11. Zhou YF, Yu ZX, Wanishsawad C, Shou M, Epstein SE. The immediate early gene products of human cytomegalovirus increase vascular smooth muscle cell migration, proliferation, and expression of PDGF β-receptor. Biochem Biophys Res Commun. 1999;256:608-613.
12. Yonemitsu Y, Kaneda Y, Komori K, Hirai K, Sugimachi K, Sueishi K. The immediate early gene of human cytomegalovirus stimulates vascular smooth muscle cell proliferation in vitro and in vivo. Biochem Biophys Res Commun. 1997;231:447-451.
13. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury, I: smooth muscle growth in the absence of endothelium. Lab Invest. 1983;49:327-333.
14. Banai S, Shou M, Correa R, Jaklitsch MT, Douek PC, Bonner RF, Epstein SE, Unger EF. Rabbit ear model of injury-induced arterial smooth muscle cell proliferation. Circulation. 1991;69:748-756.
15. Klotman ME, Henry SC, Greene RC, Brazy PC, Klotman PE, Hamilton JD. Detection of mouse cytomegalovirus nucleic acid in latently infected mice by in vitro enzymatic amplification. J Infect Dis. 1990;161: 220-225.
16. Ho M. Murine cytomegalovirus. In: Cytomegalovirus: Biology and Infection. 2nd ed. New York, NY: Plenum Medical Book Co; 1991: 329-333.
17. Sandford GR, Ho K, Burns WH. Characterization of the major locus of immediate-early genes of rat cytomegalovirus. J Virol. 1993;67: 4093-4103.
18. Gonczol E, Plotkin S. Cells infected with human cytomegalovirus release a factor(s) that stimulates cell DNA synthesis. J Gen Virol. 1984;65: 1833-1837.
19. Alcami J, Barzu T, Michelson S. Induction of an endothelial cell growth factor by human cytomegalovirus infection of fibroblasts. J Gen Virol. 1991;72:2765-2770.
20. Shibutani T, Johnson TM, Yu ZX, Ferrans VJ, Moss J, Epstein SE. Pertussis toxin sensitive G-proteins as mediators of signal transduction pathways activated by cytomegalovirus infection of smooth muscle cells. J Clin Invest. 1997;100:2054-2061.
21. Speir E, Shibutani T, Yu ZX, Ferrans V, Epstein SE. Role of reactive oxygen intermediates in cytomegalovirus gene expression and in the response of human smooth muscle cells to viral infection. Circ Res. 1996;79:1143-1152.
22. Van Dam-Mieras MCE, Muller AD, van Hinsbergh VWM, Mullers WJHA, Bomans PHH, Bruggeman CA. The procoagulant response of cytomegalovirus infected endothelial cells. Thromb Haemost. 1992;68: 364-370.
23. Etingin OR, Silverstein RL, Friedman HM, Hajjar DP. Viral activation of the coagulation cascade: molecular interactions at the surface of infected endothelial cells. Cell. 1990;61:657-662.
24. Pryzdial ELG, Wright JF. Prothrombinase assembly on an enveloped virus: evidence that the cytomegalovirus surface contains procoagulant phospholipid. Blood. 1994;84:3749-3757.
25. Grundy JE, Downes KL. Up-regulation of LFA-3 and ICAM-1 of the surface of fibroblasts infected with cytomegalovirus. Immunology. 1993; 78:405-412.
26. Span AH, Mullers W, Miltenburg AM, Bruggeman CA. Cytomegalovirus induced PMN adherence in relation to an ELAM-1 antigen present on infected endothelial cell monolayers. Immunology. 1991;72:355-360.
27. Span AH, van Dam-Mieras MC, Mullers W, Endert J, Muller AD, Bruggeman CA. The effect of virus infection on the adherence of leukocytes or platelets to endothelial cells. Eur J Clin Invest. 1991;21:331-338.
28. Etingin OR, Silverstein RL, Hajjar DP. von Willebrand factor mediates platelet adhesion to virally infected endothelium. Proc Natl Acad Sci U S A. 1993;90:5153-5156.
29. Vercellotti GM. Potential role of viruses in thrombosis and atherosclerosis. Trends Cardiovasc Med. 1995;5:128-133.
30. Visser MR, Tracy PB, Vercellotti GM, Goodman JL, White JG, Jacob HS. Enhanced thrombin generation and platelet binding on herpes simplex virus infected endothelium. Proc Natl Acad Sci U S A. 1988;85: 8227-8230.
31. Kowalik TF, Wing B, Haskill JS, Azizkhan JC, Baldwin AS, Huang ES. Multiple mechanisms are implicated in the regulation of NF-B activity during human cytomegalovirus infection. Proc Natl Acad Sci U S A. 1993;90:1107-1111.
32. Span AHM, Grauls G, Bosman F, van Boven CPA, Bruggeman CA. Cytomegalovirus infection induces vascular injury in the rat. Atherosclerosis. 1992;93:41-52.
33. Span AHM, Frederik PM, Grauls G, van Boven GPA, Bruggeman CA. CMV induced vascular injury: an electron-microscopic study in the rat. In Vivo. 1993;7:567-574.
34. Stals FS, Bosman F, van Boven CPA, Bruggeman CA. An animal model for therapeutic intervention studies of CMV infection in the immunocompromised host. Arch Virol. 1990;114:91-107.
35. Geist LJ, Monick MM, Stinski MF, Hunninghake GW. The immediate early genes of human cytomegalovirus upregulate expression of the interleukin-2 and interleukin-2 receptor genes. Am J Respir Cell Mol Biol. 1991;5:292-296.
36. Geist LJ, Monick MM, Stinski MF, Hunninghake GW. The immediate early genes of human cytomegalovirus upregulate tumor necrosis factor-α gene expression. J Clin Invest. 1994;93:474-478.
37. Lemstrom KB, Bruning JH, Bruggeman CA, Lautenschlager IT, Hayry PJ. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts. J Clin Invest. 1993;92:549-558.
38. Lemstrom KB, Bruning JH, Bruggeman CA, Lautenschlager IT, Hayry PJ. Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection. Am J Pathol. 1994;144:1334-1347.
39. Persoons MCJ, Daemen MJAP, Bruning JH, Bruggeman CA. Active cytomegalovirus infection of arterial smooth muscle cells in immunocompromised rats. Circ Res. 1994;75:214-220.